Artwork
iconShare
 
Manage episode 277770867 series 2769784
Content provided by Anika Gupta. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Anika Gupta or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Can we create new biological therapies with machine-guided design? Today I chat with Peyton Greenside, Co-Founder and CSO of BigHat Biosciences, on using machine learning to design therapeutic proteins, the advantages of using "smart" data over "big" data, and the importance of interpretability.

Check out the glossary of terms, definitions, and resources (and get a sneak peak of the future conversations lined up!) here: bit.ly/datapulse-glossary

--- Support this podcast: https://podcasters.spotify.com/pod/show/the-data-pulse/support
  continue reading

25 episodes